Intrinsiqq
iShares Biotechnology ETF logo

iShares Biotechnology ETF

IBBETF · Nasdaq

$217.01

+$0.66 (+0.31%)

EOD Oct 29, 2026

Compare IBB with another ETF

Key facts

Expense ratio
0.44%
Dividend yield (TTM)
0.15%
Distributions
Quarterly
Fund net assets (Jun 2026)
$9.1B
Stocks held
243
Other positions
5
Turnover (last fiscal year)
27%
52-week range
$154.62 to $220.21

Top 10 holdings

All holdings

50.1% of assets in ten stocks, as of Oct 28, 2026

IBB top 10 holdings by weight
CompanyWeightQuality
Gilead Sciences Inc.GILD8.40%48
Amgen Inc.AMGN8.11%48
Vertex Pharmaceuticals IncorporatedVRTX7.51%47
Regeneron Pharmaceuticals, Inc.REGN5.51%54
Moderna, Inc.MRNA5.34%20
NATERA INC (Common Stock) – ticker 45ENTRA3.90%61
argenx SE American Depositary ReceiptARGX3.39%67
Illumina, Inc.ILMN2.97%68
Revolution Medicines Inc.RVMD2.49%10
Biogen Inc.BIIB2.45%39

Sector allocation

Share of the fund's assets

  • Healthcare91.0%
  • Industrials8.3%
  • Technology0.6%
  • Materials0.0%
  • Health Care0.0%
  • Consumer Staples0.0%

Scores of what it owns

Every holding's score

Each holding's score, weighted by its size in the fund

45Qualityout of 10015Dividendout of 100

8% of the fund's stock weight sits in companies with a Quality score above 75, 64% in companies below 50.

Where it invests

Stock weight by the company's home country

  • United States89.7%
  • Belgium3.5%
  • China2.6%
  • Denmark2.2%
  • Germany0.6%
  • France0.4%
  • United Kingdom0.3%
  • Canada0.2%

And 7 more countries.

Growth of $10,000

With and without the dividends reinvested

IBB pays quarterly. Over the last twelve months it paid $0.32 per share, a 0.15% yield at today's price. The latest payment was $0.01, ex-dividend Sep 15, 2026. Over five years the annual payout grew 4.7% a year.

Average annual returns

Total return at net asset value, to Mar 31, 2026, as reported to the SEC

IBB average annual total returns
1 year5 years10 years
32.35%2.62%7.13%

Past returns say nothing certain about future ones.

IBB questions

What does IBB invest in?+

iShares Biotechnology ETF is an exchange-traded fund. Its largest holdings are Gilead Sciences Inc. (8.40%), Amgen Inc. (8.11%), Vertex Pharmaceuticals Incorporated (7.51%).

What is IBB's expense ratio?+

0.44% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $44.00 a year.

How much does IBB pay in dividends?+

IBB paid $0.32 per share over the last twelve months, a 0.15% yield at the Oct 29, 2026 close of $217.01. It pays quarterly.

How good are the companies IBB owns?+

Weighted by position size, the stocks in IBB average a Quality score of 45 out of 100. 8% of the fund's stock weight sits in companies scoring above 75, 64% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.

More on IBB: Holdings · Dividend history

Holdings: the fund's own holdings list, published by BlackRock iShares, as of Oct 28, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to Mar 31, 2026. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Oct 29, 2026.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.